Matinas BioPharma
Biotechnology Research • 
Bedminster, New Jersey, United States • 11-20 Employees
Company overview
| Headquarters | 1545 Route 206, Suite 302, Bedminster, New Jersey 07921, US |
| Phone number | +19084431860 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Founded | 2011 |
| Employees | 11-20 |
| Socials |
Key Contacts at Matinas BioPharma
Hui Liu
Chief Technology Officer
Evelyn Dan
Independent Director
Eamonn Murphy
Director Qc & Ad
David Estrada
Associate Director, Clinical Manufacturing
Matinas BioPharma Email Formats
Matinas BioPharma uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@matinasbiopharma.com), used 71.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@matinasbiopharma.com | 71.4% |
{first name}{last name} | johndoe@matinasbiopharma.com | 21.4% |
{last name}{last name} | doedoe@matinasbiopharma.com | 7.1% |
About Matinas BioPharma
Matinas BioPharma (NYSE AMER: MTNB) is a biopharmaceutical company focused on improving the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (LNC) platform technology. The Company is developing its own internal portfolio of products as well as partnering with leading pharmaceutical companies to develop novel formulations that capitalize on the unique characteristics of the LNC platform. Preclinical and clinical data have demonstrated that this novel technology can provide solutions to many of the challenges in achieving safe and effective intracellular delivery, for both small molecules and larger, more complex molecules, such as mRNA, DNA plasmids, antisense oligonucleotides, and vaccines. The combination of a unique mechanism of action and flexibility with formulation and route of administration (including oral), positions Matinas’ LNC technology to potentially become the preferred next-generation intracellular drug delivery vehicle with distinct advantages over both lipid nanoparticles and viral vectors.
Matinas BioPharma revenue & valuation
| Annual revenue | $1,096,000 |
| Revenue per employee | $61,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $3,600,000 |
| Total funding | $17,100,000 |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Matinas BioPharma has 4 employees across 4 departments.
Departments
Number of employees
Funding Data
Explore Matinas BioPharma's funding history, including investment rounds, total capital raised, and key backers.
Matinas BioPharma Tech Stack
Discover the technologies and tools that power Matinas BioPharma's digital infrastructure, from frameworks to analytics platforms.
Web servers
UI frameworks
JavaScript frameworks
Security
JavaScript libraries
Tag managers
Hosting
Analytics
JavaScript libraries
JavaScript libraries
Miscellaneous
JavaScript libraries
United Kingdom
France
Australia
Puerto Rico
Frequently asked questions
4.8
40,000 users
